ArticleInternational journal of molecular medicine2022

Transcriptome‑based drug repositioning identifies TPCA‑1 as a potential selective inhibitor of esophagus squamous carcinoma cell viability.

Zongyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.